Similar sites
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/AAura Salon – Radiate Beauty From The Inside Out
Category
N/AGlobal Rank
N/ARank in 1 month
0Estimate Value
N/A
#aura orthodontics
#braces causing nerve pain
#dr vishal sharma
#overbite correction
#how to fix overbite
#how does invisalign work
#does invisalign work
#overbite
#retainer after invisalign
#how to fix an overbite
#invisalign london
#invisalign
#teeth shifting after braces
#invisible retainers
#surgical arts center
#underbite vs overbite
#crossbite
#lingual braces
#tisseront orthodontics
#best toothpaste for braces 2021
#aura dental
#best way to clean invisalign retainers
#diastema
Malware Scan Info
Macafee Check :
Email address with auravax.com
Recent Searched Sites
Mixbot.net (1 mins ago) / US
Evergoods.us (0 seconds ago) / CA
Mnmita.com (22 seconds ago) / US
Aurabiotech.com (1 mins ago) / US
Gbta-greaterdcmetro.org (58 seconds ago) / US
Xebraworld.com (10 seconds ago) / VG
Kodaresources.com (1 mins ago) / US
Kusenjendelaaluminium.com (1 mins ago) / ID
Restaurantsokolovna.cz (1 mins ago) / CZ
Timedna.com (2 seconds ago) / US
Defenseone.com (38 seconds ago) / US
Timeular.com (46 seconds ago) / US
Gbattery.saramin.co.kr (1 mins ago) / KR
Poulsmindeudlejning.dk (7 seconds ago) / DK
Kak-svoimi-rukami.com (21 seconds ago) / US
Safetravelusa.com (32 seconds ago) / US
Dmh.mo.gov (25 seconds ago) / US
Gurasen.com (18 seconds ago) / JP
Auravax.com (0 seconds ago) / US
Ketabkadekoodak.ir (22 seconds ago) / IR
Domain Informations
Auravax.com lookup results from whois.godaddy.com server:
- Domain created: 2020-09-18T00:44:30Z
- Domain updated: 2022-11-18T22:27:24Z
- Domain expires: 2024-09-18T00:44:30Z 0 Years, 206 Days left
- Website age: 3 Years, 158 Days
- Registrar Domain ID: 2560495386_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS57.DOMAINCONTROL.COM
- NS58.DOMAINCONTROL.COM
Network
- inetnum : 35.192.0.0 - 35.207.255.255
- name : GOOGLE-CLOUD
- handle : NET-35-192-0-0-1
- status : Direct Allocation
- created : 2006-09-29
- changed : 2019-11-01
- desc : *** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,*** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
- organization : Google LLC
- handle : GOOGL-2
- address : Array,Mountain View,CA,94043,US
Abuse
- handle : GCABU-ARIN
- name : GC Abuse
- phone : +1-650-253-0000
- email : [email protected]
Technical support
- handle : ZG39-ARIN
- name : Google LLC
- phone : +1-650-253-0000
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 677172 |
namecheap.com | 222288 |
networksolutions.com | 162745 |
tucows.com | 138311 |
publicdomainregistry.com | 89698 |
whois.godaddy.com | 61539 |
enomdomains.com | 58960 |
namesilo.com | 49196 |
gmo.jp | 45778 |
cloudflare.com | 45208 |
register.com | 39251 |
fastdomain.com | 38826 |
ionos.com | 33441 |
name.com | 32856 |
wildwestdomains.com | 32439 |
net.cn | 31628 |
domains.google.com | 30670 |
registrar.amazon.com | 29466 |
key-systems.net | 26853 |
Host Informations
Host name | 53.123.196.35.bc.googleusercontent.com |
IP address | 35.196.123.53 |
Location | United States |
Latitude | 38.6583 |
Longitude | -77.2481 |
Timezone | America/New_York |
Port Scanner (IP: 35.196.123.53)
Spam Check (IP: 35.196.123.53) › Dnsbl-1.uceprotect.net:
› Dnsbl-2.uceprotect.net:
› Dnsbl-3.uceprotect.net:
› Dnsbl.dronebl.org:
› Dnsbl.sorbs.net:
› Spam.dnsbl.sorbs.net:
› Bl.spamcop.net:
› Recent.dnsbl.sorbs.net:
› All.spamrats.com:
› B.barracudacentral.org:
› Bl.blocklist.de:
› Bl.emailbasura.org:
› Bl.mailspike.org:
› Bl.spamcop.net:
› Cblplus.anti-spam.org.cn:
› Dnsbl.anticaptcha.net:
› Ip.v4bl.org:
› Fnrbl.fast.net:
› Dnsrbl.swinog.ch:
› Mail-abuse.blacklist.jippg.org:
› Singlebl.spamgrouper.com:
› Spam.abuse.ch:
› Spamsources.fabel.dk:
› Virbl.dnsbl.bit.nl:
› Cbl.abuseat.org:
› Dnsbl.justspam.org:
› Zen.spamhaus.org:
Site Inspections
Websites Listing
We found Websites Listing below when search with auravax.com on Search Engine
AuraVax Therapeutics Enters into Exclusive License Agreement …
AuraVax Therapeutics Inc. ("AuraVax") is a privately held biotechnology company developing a proprietary and differentiated platform of vaccines and therapeutics. Its lead candidate is an ...
Finance.yahoo.comDA: 17 PA: 50 MOZ Rank: 83
Auravax Therapeutics Announces Formation of Scientific
AuraVax Therapeutics, Inc. ("AuraVax") is a privately held biotechnology company developing a proprietary and differentiated platform of vaccines and therapeutics for respiratory diseases. Its lead candidates are an intranasal therapeutic and vaccine for COVID-19. Its next-generation platform aims to combine the ease of use of "at-home" administration, superior …
Biospace.comDA: 16 PA: 50 MOZ Rank: 49
Varadarajan Partners With Auravax Therapeutics On COVID-19 …
About AuraVax. AuraVax Therapeutics, Inc. (“AuraVax”) is a privately held biotechnology company developing a proprietary and differentiated platform of vaccines against various respiratory viruses including COVID-19. Its next-generation vaccine platform combines the potential of in-home administration with the ability to deliver complete ...
Egr.uh.eduDA: 14 PA: 50 MOZ Rank: 98
AuraVax Therapeutics Enters into Exclusive License Agreement …
AuraVax Therapeutics Inc. ("AuraVax") is a privately held biotechnology company developing a proprietary and differentiated platform of vaccines and therapeutics. Its lead candidate is an intranasal vaccine for COVID-19. Its next-generation platform aims to combine the ease of use of "at-home" administration with the ability to deliver ...
Pipelinereview.comDA: 18 PA: 50 MOZ Rank: 47
University of Houston Partners with AuraVax Therapeutics on …
AuraVax Therapeutics, Inc. (“AuraVax”) is a privately held biotechnology company developing a proprietary and differentiated platform of vaccines against various respiratory viruses including COVID-19. Its next-generation vaccine platform combines the potential of in-home administration with the ability to deliver complete immunity. The technology has been validated …
Uh.eduDA: 6 PA: 50 MOZ Rank: 46
COVID-19 nasal vaccine candidate effective at preventing disease ...
Varadarajan is co-founder of AuraVax Therapeutics Inc., a pioneering biotech company developing novel intranasal vaccines and therapies to help patients defeat debilitating diseases, including ...
Sciencedaily.comDA: 20 PA: 34 MOZ Rank: 59
Intranasal vaccines for SARS-CoV-2: From challenges to potential …
AuraVax Therapeutics has a liposomal stimulator of interferon genes or STING agonist technology licensed from Massachusetts General Hospital (MGH) for use as an adjuvant in vaccines against COVID-19 and other respiratory diseases. Research evidenced that triggering a mucosal immune response can evoke rapid and durable protection against pandemic viruses, …
Ncbi.nlm.nih.govDA: 20 PA: 25 MOZ Rank: 51
AuraVax Therapeutics Enters into Exclusive License Agreement …
AuraVax Therapeutics Inc. ("AuraVax") is a privately held biotechnology company developing a proprietary and differentiated platform of vaccines and therapeutics. Its lead candidate is an intranasal vaccine for COVID-19. The next-generation platform aims to combine the ease of use of "at-home" administration with the ability to deliver comprehensive immunity …
Biospace.comDA: 16 PA: 50 MOZ Rank: 43
Aravive, Inc. (ARAV) Stock Price, News, Quote & History - Yahoo
Find the latest Aravive, Inc. (ARAV) stock quote, history, news and other vital information to help you with your stock trading and investing.
Finance.yahoo.comDA: 17 PA: 12 MOZ Rank: 37
University of Houston Partners with AuraVax Therapeutics on …
The University of Houston has entered into an exclusive license option agreement with AuraVax Therapeutics Inc., a Houston, TX based biotech company developing novel vaccines to help patients defeat debilitating respiratory diseases such as COVID-19. Under terms of the agreement, AuraVax has the option to exclusively license a new intranasal COVID-19 …
Egr.uh.eduDA: 14 PA: 50 MOZ Rank: 41
AuraVax Therapeutics Enters into Exclusive License Agreement
AuraVax Therapeutics Inc. ("AuraVax") is a privately held biotechnology company developing a proprietary and differentiated platform of vaccines and therapeutics. Its lead candidate is an ...
Wfmz.comDA: 12 PA: 50 MOZ Rank: 40
University of Houston partners Indian-American co-founded …
AuraVax, however, has the option to exclusively license a new intranasal vaccine technology developed by its Indian-American co-founder, Navin Varadarajan, M.D. Anderson Professor of Chemical and ...
Health.economictimes.indiatimes.comDA: 35 PA: 50 MOZ Rank: 39
University of Houston, AuraVax Therapeutics partner for COVID-19 ...
On Monday, officials with the University of Houston announced that the school has entered into an exclusive license option agreement with AuraVax Therapeutics Inc ., a Houston based biotech company developing novel vaccines to help patients defeat debilitating respiratory diseases such as COVID-19. Under terms of the agreement, AuraVax has the ...
Elpasoheraldpost.comDA: 20 PA: 50 MOZ Rank: 38
University of Houston partners with AuraVax T | EurekAlert!
AuraVax Therapeutics, Inc. ("AuraVax") is a privately held biotechnology company developing a proprietary and differentiated platform of …
Eurekalert.orgDA: 18 PA: 21 MOZ Rank: 52
Patient Information VARIVAX® (pronounced “VAR ih vax”) …
Patient Information VARIVAX® (pronounced “VAR ih vax”) Varicella Virus Vaccine Live This is a summary of information about VARIVAX®. You should read it before you or your child get the
Fda.govDA: 11 PA: 21 MOZ Rank: 46
University of Houston partners with AuraVax Therapeutics to …
The University of Houston has partnered with AuraVax Therapeutics to develop cutting-edge COVID vaccine The vaccine is a nasal inhalant, much like FluMist. Based on experiments, it …
Abc13.comDA: 9 PA: 44 MOZ Rank: 68
COVID-19: University of Houston partners Indian-American co …
AuraVax, however, has the option to exclusively license a new intranasal vaccine technology developed by its Indian-American co-founder, Navin Varadarajan, M.D. Anderson Professor of Chemical and Biomolecular Engineering at the University of Houston. A safe and durable vaccine is urgently needed to tackle the COVID-19 pandemic that has infected millions …
Cnbctv18.comDA: 16 PA: 50 MOZ Rank: 34
Single-dose intranasal vaccination elicits systemic and mucosal ...
Despite progress at remarkable speed, current intramuscular vaccines are designed to elicit systemic immunity without conferring mucosal immunity. We report the development of an intranasal subunit vaccine that contains the trimeric or monomeric spike protein and liposomal STING agonist as adjuvant. This vaccine induces systemic neutralizing ...
Pubmed.ncbi.nlm.nih.govDA: 23 PA: 10 MOZ Rank: 50
Wilson Sonsini Advises AuraVax on Exclusive License Agreement …
On January 13, 2021, AuraVax Therapeutics Inc., a biotech company developing novel vaccines and therapies to help patients defeat debilitating diseases, including COVID-19, announced it has entered into an exclusive license agreement with Massachusetts General Hospital (MGH) covering certain intellectual property and technology rights regarding …
Wsgr.comDA: 12 PA: 50 MOZ Rank: 32
IN THROUGH THE NOSE...
Varadarajan is co-founder of AuraVax Therapeutics Inc., a pioneering biotech company developing novel intranasal vaccines and therapies to help patients defeat debilitating diseases, including COVID-19. The company has an exclusive license agreement with UH with respect to the intellectual property covering intranasal vaccines and STING agonist technologies. They …
Stories.uh.eduDA: 14 PA: 41 MOZ Rank: 74
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
tagon4.ca | ca.godaddy.com | 353 Days |
smsreceivenow.com | namesilo.com | 349 Days |
credibilityservicesinternational.com | register.com | 90 Days |
sxpdtextile.com | enomdomains.com | 301 Days |
schonestaxservice.com | enomdomains.com | 321 Days |
islamitradicional.com | cloudflare.com | 160 Days |
idemia-nss.com | godaddy.com | 1 Year, 216 Days |